The Oncology Institute Inc (TOI)
1.16
-0.02
(-1.69%)
USD |
NASDAQ |
Apr 26, 16:00
1.16
0.00 (0.00%)
After-Hours: 20:00
Oncology Institute SG&A Expense (Quarterly): 28.09M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 28.09M |
September 30, 2023 | 28.20M |
June 30, 2023 | 28.73M |
March 31, 2023 | 28.83M |
December 31, 2022 | 29.57M |
September 30, 2022 | 31.96M |
June 30, 2022 | 28.35M |
March 31, 2022 | 29.81M |
Date | Value |
---|---|
December 31, 2021 | 48.24M |
September 30, 2021 | 12.73M |
June 30, 2021 | 11.21M |
March 31, 2021 | 11.18M |
December 31, 2020 | 41.57M |
September 30, 2020 | 0.1485M |
June 30, 2020 | 8.547M |
December 31, 2018 | 8.834M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.1485M
Minimum
Sep 2020
48.24M
Maximum
Dec 2021
24.48M
Average
28.35M
Median
Jun 2022
SG&A Expense (Quarterly) Benchmarks
Encompass Health Corp | 743.40M |
Pediatrix Medical Group Inc | 53.06M |
US Physical Therapy Inc | -- |
US Neurosurgical Holding Inc | 0.243M |
American Oncology Network Inc | 27.88M |